Cagrilintide

Concentration: Commonly 5 mg, 10 mg, or 20 mg vials (lyophilized powder)

Composition: Synthetic long-acting amylin analog

Formulation: Lyophilized acetate salt

Half-Life: ~6–8 days (extended via structural modification)

Primary Actions: Appetite suppression, satiety signaling, metabolic research

Studied for reducing food intake and supporting weight loss.

Explored for synergistic effects when combined with GLP-1 analogs.

Shown to influence energy balance and adiposity regulation.

Considered part of the next-gen obesity research compounds.

Reconstitute with bacteriostatic water (NuroCore standard).

Swirl gently until dissolved.

Handle under sterile laboratory conditions.

Unreconstituted: Store at –20 °C.

Reconstituted: Refrigerate at 2–8 °C.

Appearance: Clear, colorless solution; discard if cloudy or particulate.

Category: Metabolic & Weight Management Research (NuroCore)

Use Case: Research into amylin pathways, appetite suppression, and obesity studies

Compliance Note: Classified strictly as a research compound